908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

908 Devices Inc.NASDAQ: MASS

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 14.7% from a year ago

Cash & equivalents stood at $67.56M at the end of Q1 FY2026, down 14.7% from a year earlier and down 4.2% from the prior quarter. Over 3 fiscal years it compounded at -15.7% a year.

Context

  • Cash & equivalents amounted to 36.2% of total assets at the end of Q1 FY2026, down 4.2 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -14.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$67.56M-4.2% QoQ
Last fiscal yearDec 2025
$112.97M+156.6% YoY
Year agoMar 2025
$79.16M-14.7% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-14.7%——
1 year+156.6%——
3-year CAGR-15.7%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
112.97M USD
Year-over-year change
+156.6%
4-year CAGR
-15.7%

Cash & Equivalents vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's Mar 2026 cash & equivalents of $67.56M is the lowest of the 3 companies compared; the peer median is $1.26B.
  • Its year-over-year change of -14.7% is the lowest of 3, against a peer median of +9.6%.
  • Cash & equivalents amounts to 36.2% of total assets for MASS, versus a peer median of 12.8%.
MASS Competitors Peer median
Cash & Equivalents for MASS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AAgilent Technologies, Inc.Jul 2026$1.76B +14.5%+19.3%12.6%
QGENQiagen N.V.Jun 2026$768.5M +4.7%+4.7%13.0%
MASS908 Devices Inc.Mar 2026$67.56M -14.7%-15.7%36.2%
Peer median (excluding MASS) $1.26B+9.6%+12.0%12.8%

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents224.07M188.42M121.04M44.03M112.97M
Short-term Investments0024.64M25.57M0
Net Receivables16.58M10.03M8.99M12.63M11.33M
Inventory7.92M12.51M14.94M16.17M12.99M
Other Current Assets60K4.66M4.18M4.66M7.27M
Total Current Assets252.89M215.63M173.79M103.06M144.56M
Property, Plant & Equipment (Net)6.79M7.04M9.58M10.33M8.63M
Goodwill010.05M10.37M00
Intangible Assets08.49M7.86M45.26M36.41M
Long-term Investments00171K00
Tax Assets00000
Other Non-current Assets1.23M1.38M1.22M829K471K
Total Non-current Assets8.01M26.96M29.19M56.42M45.51M
Total Assets260.91M242.59M202.98M159.48M190.07M
Account Payables1.37M1.4M1.19M2.06M8.42M
Short-term Debt002.02M1.87M16.71M
Tax Payables00000
Deferred Revenue5.16M7.51M10.63M12.13M8.93M
Other Current Liabilities3.27M3.94M2.72M9.1M0
Total Current Liabilities14.84M19.23M22.55M25.15M34.06M
Long-term Debt15M15M000
Deferred Tax Liabilities02.67M2.44M2.03M0
Deferred Revenue (Non-current)011.5M8.57M10.68M8.33M
Other Non-current Liabilities11.96M555K02.28M3.98M
Total Non-current Liabilities31.47M32.76M14.94M19.74M12.31M
Total Liabilities46.3M51.99M37.49M44.88M46.37M
Common Stock31K32K33K35K36K
Retained Earnings(100.64M)(134.2M)(170.6M)(242.81M)(223.32M)
Accumulated OCI0798K1.37M1.15M54K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity214.6M190.6M165.49M114.59M143.7M
Total Debt20.85M19.51M5.95M6.61M16.71M
Net Debt(203.22M)(168.91M)(115.1M)(37.43M)(96.26M)

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.